Microglia: A Potential Drug Target for Traumatic Axonal Injury
Traumatic axonal injury (TAI) is a major cause of death and disability among patients with severe traumatic brain injury (TBI); however, no effective therapies have been developed to treat this disorder. Neuroinflammation accompanying microglial activation after TBI is likely to be an important fact...
Main Authors: | Xin Huang, Wendong You, Yuanrun Zhu, Kangli Xu, Xiaofeng Yang, Liang Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2021/5554824 |
Similar Items
-
A Retrospective Clinical Analysis of the Serum Bile Acid Alteration Caused by Traumatic Brain Injury
by: Yuanrun Zhu, et al.
Published: (2021-08-01) -
Animal model of repetitive mild traumatic brain injury for human traumatic axonal injury and chronic traumatic encephalopathy
by: Leyan Xu
Published: (2015-01-01) -
Microglia dynamics in adolescent traumatic brain injury
by: Eric Eyolfson, et al.
Published: (2020-10-01) -
Traumatic Brain Injury, Microglia, and Beta Amyloid
by: Rebekah C. Mannix, et al.
Published: (2012-01-01) -
Microglia: roles and rules in brain traumatic injury
by: Hernando Raphael Alvis-Miranda, et al.
Published: (2013-03-01)